 Zhejiang Chiral Medicine Chemicals Co.,Ltd. (CMC) was established in 1998, acquired by Zhejiang Yongtai Technology Co., Ltd. in 2016.Zhejiang Chiral became a wholly-owned subsidiary of Yongtai Technology Co., Ltd. Located in Xiaoshan Nanyang Economic Development Zone, Zhejiang Chiral Medicine Chemicals Co., Ltd occupies an area of 15,000 square meters.
The company, specializing in generic APIs and pharmaceutical intermediates, has been accredited as a high-tech enterprise by Zhejiang Province Government. There are more than 300 employees, and 25% are of them are skilled technicians and managers with middle and senior titles. With powerful developing and manufacturing capabilities, as well as high quality and level sales personnel, CMC strives to meet the requirements of our customers with the highest integration of enterprise operation model. We are particularly specialized in synthesizing chiral pharmaceutical products, which is also the main direction of the company. Zhejiang Chiral Medicine Chemicals Co., Ltd. now has obtained two US patents and seven invention patents. Up to now, our APIs (gabapentin, carbidopa, etodolac) have successfully certificated to US FDA, Australian official and South Korea KFDA, and have successfully got the EU CEP certificate and China GMP certificate; therefore, our company has become one of the main API (gabapentin) suppliers in the global market. Based on the concept of "safety, environmental protection, quality, and innovation", our company strives to be a world-renowned manufacturer and supplier of API. |
